8610733

Source:http://linkedlifedata.com/resource/pubmed/id/8610733

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0001779, umls-concept:C0002199, umls-concept:C0023473, umls-concept:C0030705, umls-concept:C0087111, umls-concept:C0439234, umls-concept:C1274040
pubmed:issue	4
pubmed:dateCreated	1996-5-30
pubmed:abstractText	To determine the response rate to interferon-alpha (IFN-alpha) in patients with chronic myelogenous leukemia (CML) aged 60 years and older.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0267200
pubmed:citationSubset	AIM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, http://linkedlifedata.com/resource/pubmed/chemical/Hydroxyurea, http://linkedlifedata.com/resource/pubmed/chemical/Interferon-alpha, http://linkedlifedata.com/resource/pubmed/chemical/Interferon-gamma
pubmed:status	MEDLINE
pubmed:month	Apr
pubmed:issn	0002-9343
pubmed:author	pubmed-author:CortesJJ, pubmed-author:KantarjianHH, pubmed-author:O'BrienSS, pubmed-author:PierceSS, pubmed-author:RobertsonL ELE, pubmed-author:TalpazMM
pubmed:issnType	Print
pubmed:volume	100
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	452-5
pubmed:dateRevised	2008-11-21
pubmed:meshHeading	pubmed-meshheading:8610733-Age Factors, pubmed-meshheading:8610733-Aged, pubmed-meshheading:8610733-Antineoplastic Agents, pubmed-meshheading:8610733-Basophils, pubmed-meshheading:8610733-Bone Marrow, pubmed-meshheading:8610733-Chronic Disease, pubmed-meshheading:8610733-Fatigue, pubmed-meshheading:8610733-Follow-Up Studies, pubmed-meshheading:8610733-Humans, pubmed-meshheading:8610733-Hydroxyurea, pubmed-meshheading:8610733-Interferon-alpha, pubmed-meshheading:8610733-Interferon-gamma, pubmed-meshheading:8610733-Leukemia, Myelogenous, Chronic, BCR-ABL Positive, pubmed-meshheading:8610733-Middle Aged, pubmed-meshheading:8610733-Nervous System Diseases, pubmed-meshheading:8610733-Remission Induction, pubmed-meshheading:8610733-Survival Rate, pubmed-meshheading:8610733-Texas
pubmed:year	1996
pubmed:articleTitle	Result of interferon-alpha therapy in patients with chronic myelogenous leukemia 60 years of age and older.
pubmed:affiliation	Department of Hematology, University of Texas, M.D. Anderson Cancer Center, Houston 77030, USA.
pubmed:publicationType	Journal Article, Clinical Trial, Comparative Study, Controlled Clinical Trial